BiltRx

The catalogue is broad. Compounded semaglutide and tirzepatide, alongside four FDA-approved brand-name GLP-1 products; testosterone for men; compounded bioidentical hormone therapy for women 35 and older; NAD+, glutathione, B12 and Lipo-C; sermorelin and tesamorelin; PT-141 and ED tablets; and minoxidil and finasteride for hair loss. Most treatments are priced per month.

Compounded drugs are not FDA-approved. BiltRx’s own pages say so: “Compounded medications are not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness, or quality.” Its GLP-1 pages also say that clinical-trial results it describes come from studies of the FDA-approved brand-name medications, not compounded versions. Nothing on this page is medical advice, and nothing here says any treatment is appropriate for any particular reader — that is what the provider review is for.

1. An account and an intake. Each treatment page’s “Get Started” button opens an intake form hosted on Tellescope, a third-party healthcare forms platform. TRT and some other treatments require lab work; BiltRx’s Terms name LabCorp and myLAB Box as laboratories.
2. A provider reviews it. The Terms of Service name two medical groups, Bask Health and Openloop, whose physicians and other clinicians provide care through the platform, and its telehealth consent lists the Openloop, Reliant.MD and MECNB physician practices by name. BiltRx states that consultations are by phone or video with licensed U.S. providers; Prof. Peptide has read no licence for any of them.
3. A pharmacy fills and ships. Prescriptions are filled by third-party compounding pharmacies and mailed to the patient; some prescriptions, most often for commercially available medications, can be sent to a local pharmacy instead. BiltRx’s FAQ says most prescriptions are processed within 1 to 3 business days and most patients receive medication within 3 to 7 business days of approval. Medication ships only within the United States.
4. Ongoing subscription. Some products are sold as subscriptions that renew automatically until cancelled; BiltRx says a one-time purchase is always an option. Women’s hormone therapy renews every 3 months through a link sent by text or email.

Membership

BiltRx’s FAQ describes a $9.99 monthly membership covering care coordination, priority support and member pricing on supplements, with consultation fees and medication costs billed separately.

Consultation and shipping

Every medication page says “Consultation and shipping apply separately.” The amounts are published only on the women’s hormone therapy page.

Insurance

Cash-pay. The Terms say BiltRx and its medical groups do not take part in Medicare or Medicaid. The FAQ says some HSA and FSA cards may be eligible. A separate form checks insurance coverage for brand-name GLP-1 products.

Cancelling

The Terms say orders cannot be cancelled once a licensed provider has approved the prescription. Subscriptions renew each cycle until the customer cancels.

Refunds

No refund policy is published. The Terms say BiltRx resolves customer issues case by case, and that it may cancel and refund an order affected by an error, including a pricing error.

Prices are BiltRx’s and change without notice to Prof. Peptide. The date above is the date Prof. Peptide read them, not a promise about today.

The GLP-1 treatments sit in a changed landscape. FDA determined the tirzepatide injection shortage resolved on 19 December 2024 and the semaglutide injection shortage resolved on 21 February 2025, and the period of enforcement discretion for 503A compounding of semaglutide ended on 28 April 2025. FDA states that when a shortage is resolved it generally considers the drug commercially available, and section 503A restricts compounding drugs that are essentially copies of a commercially available drug product. Prof. Peptide draws no conclusion from that — whether a given preparation is essentially a copy turns on a prescriber’s determination that Prof. Peptide cannot see. It is reported here because the dates are public and material.

• The link on this page goes where it says. Every button here points at Prof. Peptide’s own redirect, /go/biltrx, which leads to BiltRx’s homepage. A build check refuses any link on this page that points anywhere else.
• Every price came off a BiltRx page. Every treatment page in BiltRx’s sitemap was read, along with its category, FAQ, terms, promotions and state pages. Where two BiltRx pages give different figures for one product, both are reported above.
• The legal documents name the company and its partners. The Terms of Service name BiltRx Inc. (DBA BiltRx) as the operator, Bask Health and Openloop as the medical groups, GoGo Meds and Tailor Made Compounding Pharmacy as pharmacies, and LabCorp and myLAB Box as laboratories, and are governed by California law. The contact details BiltRx publishes are 17350 State Highway 249, Ste 220, Houston, TX 77064, +1 800-581-2954 and care@biltrx.com.
• The two pharmacy lists do not match. BiltRx’s homepage FAQ names Southend Pharmacy and Boothwyn Pharmacy; its Terms name GoGo Meds and Tailor Made Compounding Pharmacy. Neither document says which list is current.
• LegitScript could not be confirmed. BiltRx describes itself as LegitScript-certified, and its pages carry a LegitScript seal linking to LegitScript’s own lookup for biltrx.com. That lookup asks for a reCAPTCHA before it shows a result, so Prof. Peptide has not read one, and the certification stays BiltRx’s statement.

What is BiltRx’s own account. BiltRx states that it has “10,000+” patients, that its providers are licensed in the U.S., that its women’s hormone physicians are board-certified, that it is a Google-verified online pharmacy, and that its partner pharmacies are FDA-registered and U.S.-licensed. Its About page says it was founded in July 2022 by Joe Duarte with Nishant Rao, whom its Medical Review page lists as a naturopathic doctor (ND) and medical reviewer of its content. None of these came with a document Prof. Peptide could read, so none is repeated here as fact.